Financial Summary -
Business Pharma Consulting Srl
Unique identification code:37611216
Registration number:J2017002396239
Nace:4711
Sales - Ron
174.623
Net Profit - Ron
46.173
Employees
10
Open Account
Company Business Pharma Consulting Srl with Fiscal Code 37611216
recorded a turnover of 2024 of
174.623,
with a net profit of
46.173
and having an average number of employees of
10.
The company operates in the field of CAEN Ver.3: Comerţ cu amănuntul nespecializat, cu vânzare predominantă de produse alimentare, băuturi şi tutun; CAEN Ver.2: Comert cu amanuntul in magazine nespecializate, cu vanzare predominanta de produse alimentare, bauturi si tutun; having the NACE code 4711.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Business Pharma Consulting Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
-
-
-
-
0
0
0
51.296
94.500
174.623
Total Income - EUR
-
-
-
-
0
0
0
51.296
94.500
174.623
Total Expenses - EUR
-
-
-
-
0
0
0
19.278
26.098
124.006
Gross Profit/Loss - EUR
-
-
-
-
0
0
0
32.018
68.402
50.618
Net Profit/Loss - EUR
-
-
-
-
0
0
0
31.516
67.476
46.173
Employees
-
-
-
-
0
0
0
3
3
10
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 85.8%, from 94.500 euro in the year 2023, to 174.623 euro in 2024.
The Net Profit decreased by -20.926 euro, from 67.476 euro in 2023, to 46.173 in the last year.
Check the financial reports for the company - Business Pharma Consulting Srl
Financial Rating - BUSINESS PHARMA CONSULTING SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Business Pharma Consulting Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Business Pharma Consulting Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Business Pharma Consulting Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Business Pharma Consulting Srl - CUI 37611216
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
-
-
-
-
19
19
18
18
18
21.569
Current Assets
-
-
-
-
2.460
2.413
2.360
35.802
82.961
77.841
Inventories
-
-
-
-
0
0
0
0
0
1.531
Receivables
-
-
-
-
0
0
0
19.074
67.459
67.619
Cash
-
-
-
-
2.460
2.413
2.360
16.728
15.502
8.691
Shareholders Funds
-
-
-
-
2.479
2.432
2.378
33.901
67.525
46.221
Social Capital
-
-
-
-
42
41
40
41
40
40
Debts
-
-
-
-
0
0
0
1.920
15.455
53.190
Income in Advance
-
-
-
-
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4711 - 4711"
CAEN Financial Year
4711
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
77.841 euro in 2024 which includes Inventories of
1.531 euro, Receivables of
67.619 euro and cash availability of
8.691 euro.
The company's Equity was valued at
46.221 euro, while total Liabilities amounted to
53.190 euro.
Equity decreased by -20.926 euro, from 67.525 euro in 2023, to 46.221 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Business Pharma Consulting Srl